agilon health, inc. Discontinued Operation, Tax Effect of Discontinued Operation
agilon health, inc. (AGL) reported Discontinued Operation, Tax Effect of Discontinued Operation of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2025-02-25
- agilon health, inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2023-12-31 was $0.00.
- agilon health, inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- agilon health, inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- agilon health, inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2022-12-31 was $0.00.
- agilon health, inc. discontinued operation, tax effect of discontinued operation for fiscal 2024 was $0.00.
- agilon health, inc. discontinued operation, tax effect of discontinued operation for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- agilon health, inc. discontinued operation, tax effect of discontinued operation for fiscal 2022 was $26.00K.
- agilon health, inc. discontinued operation, tax effect of discontinued operation for fiscal 2021 was -$1.69M.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $12.00K derived: sum of 2 quarters · filed 2025-02-25 | $26.00K derived: sum of 3 quarters · filed 2025-02-25 | $26.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $12.00K 10-Q · filed 2023-11-02 | $26.00K derived: sum of 2 quarters · filed 2023-11-02 | $26.00K 10-Q · filed 2023-11-02 | -$1.87M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $14.00K 10-Q · filed 2023-08-03 | $14.00K 10-Q · filed 2023-08-03 | -$1.88M derived: sum of 3 quarters · filed 2024-02-27 | -$1.80M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | -$1.90M derived: sum of 2 quarters · filed 2024-02-27 | -$1.82M derived: sum of 3 quarters · filed 2024-02-27 | -$1.75M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.82M derived: sum of 2 quarters · filed 2024-02-27 | -$1.75M derived: sum of 3 quarters · filed 2024-02-27 | -$1.69M 10-K · filed 2024-02-27 |
| 2021-09-30 | $82.00K 10-Q · filed 2022-11-03 | $147.00K derived: sum of 2 quarters · filed 2022-11-03 | $211.00K 10-Q · filed 2022-11-03 | -$2.98M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $65.00K 10-Q · filed 2022-08-04 | $129.00K 10-Q · filed 2022-08-04 | -$3.06M derived: sum of 3 quarters · filed 2023-03-01 | -$2.95M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $64.00K 10-Q · filed 2022-05-05 | -$3.13M derived: sum of 2 quarters · filed 2023-03-01 | -$3.02M derived: sum of 3 quarters · filed 2023-03-01 | -$2.89M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$3.08M derived: sum of 2 quarters · filed 2023-03-01 | -$2.95M derived: sum of 3 quarters · filed 2023-03-01 | -$2.80M 10-K · filed 2023-03-01 |
| 2020-09-30 | $110.00K 10-Q · filed 2021-10-28 | $236.00K derived: sum of 2 quarters · filed 2021-10-28 | $385.00K 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $126.00K 10-Q · filed 2021-08-04 | $275.00K 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $149.00K 10-Q · filed 2021-05-26 | |||
| 2019-12-31 | -$16.17M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |